Barchart on MSN9h
This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here.
Growing demand for weight-loss solutions has catapulted pharmaceutical firms like Eli Lilly (LLY) and Novo Nordisk (NVO) into ...
Outsourcing-pharma16h
Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials
Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...
Novo Nordisk shares surge on results of new obesity drug trial
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
Oprah Winfrey shares the type of weight loss medication she took
Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...
The Lancet7h
Weight-loss medications: promoting health and not harm
In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...
The New York Times14h
New York Times - Top Stories
Funding Freeze Sets Off New Fight Over Trump’s Vision for His Government President Trump’s order freezing trillions of dollars in federal grants and loans seeks to eliminate all spending on ...